Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Stanford Team Generates Light Inside Deep Tissue Using Ultrasound‑Activated Nanoparticles
Stanford scientists have shown that ultrasound can activate specially engineered nanophosphors circulating in the bloodstream to emit light deep inside living tissue. The breakthrough, demonstrated in mice, could replace invasive fiber‑optic probes for optogenetics, imaging and cancer treatment.
The Financial Impact of Low Engagement in Digital Health Programmes
Digital health programs are proliferating in insurance, but low ongoing engagement erodes their value. Insurers that only track downloads miss out on cost reductions, richer underwriting data, and customer retention benefits. Research from dacadoo shows sustained app usage can cut...
Kennedy Returns to Capitol Hill with Clout Diminished
Health Secretary Robert F. Kennedy Jr. will appear before the House Ways and Means and Appropriations committees for the first time in six months, signaling a sharp drop in his political clout. Lawmakers will grill him on a controversial overhaul...
Pharma Pulse: Walgreens’ New Hybrid Pharmacist Model, Pharmacies Expand Injectable Access, and More
Walgreens is launching a hybrid pharmacist model that blends in‑store duties with centralized, remote clinical work to ease staffing pressures and boost medication therapy management. A new study highlights community pharmacies’ expanding role as key sites for immunizations and injectable...
Johnson & Johnson’s Experience Navigating The Commissioner’s National Priority Voucher Program
Johnson & Johnson’s hematology division secured FDA approval for a new multiple myeloma regimen—Tecvayli plus Darzalex Faspro—through the FDA Commissioner’s National Priority Voucher pilot. The approval came just 55 days after filing, marking the first blood‑cancer therapy to use the voucher...
California Sees the Most Measles Cases in 7 Years as Disease Resurges Nationwide
California has recorded at least 40 confirmed measles cases in 2026, the highest annual tally in the state since 2019 and surpassing the 25 cases reported in 2025. Health officials say 95% of the cases involve unvaccinated or unknown‑status individuals,...
Breakthrough Science, Unequal Survival
Recent breakthroughs such as routine stem‑cell transplants and CAR‑T therapy have transformed treatment for several blood cancers, delivering long‑term remission for patients once deemed incurable. Yet blood cancer remains the UK’s third‑largest cancer killer, with 310,000 people living with or...
Hong Kong’s Largest Hospital, Kai Tak Hospital, to Open in October
Hong Kong will open its largest public hospital, Kai Tak Hospital, in October, offering 2,400 beds within a 500,000‑sqm healthcare hub. The first phase will provide specialist outpatient services in medicine, neurosurgery and oncology, while accident‑and‑emergency, inpatient and surgical care are...
Ambition Into Action: Delivering the Future of the National Cancer Plan
The UK’s National Cancer Plan sets out an ambitious agenda to boost early diagnosis, speed treatment access and personalize care, positioning cancer outcomes as a barometer for the NHS. AstraZeneca’s Cancer: Project Zero and other partners are tasked with scaling...
Equality in Cancer Care Shouldn’t Be a Aspiration – It Must Be the Standard
A persistent postcode lottery means cancer outcomes vary dramatically across England, with patients in deprived areas and ethnic minorities facing later diagnoses and poorer survival. Community‑based services like Beechwood Cancer Care demonstrate the benefits of holistic, person‑centred support, but such...
Dakota Forms Partnership with Pocketalk to Bring Easy-To-Use Two-Way Translation to the Healthcare Sector
Dakota Integrated Solutions has partnered with Pocketalk to embed a two‑way translation device and enterprise app into its healthcare product line. The handheld Pocketalk unit translates spoken and written language in real time, featuring a noise‑cancelling microphone and support for...
Rebuild, Don’t Just Relieve Pain: The Peptide Revolution for Lasting Joint Health
In this episode, host Steve discusses chronic inflammation and joint pain with Dr. Peter McCullough, chief scientific officer of a wellness company. Dr. McCullough explains how traditional pain relievers only mask symptoms, while their peptide‑based products—Regenerate (oral drops) and Therablu (topical...
Venture Philanthropy: Revolution Through Collaboration
Macmillan Cancer Support is establishing a second impact fund, Macmillan Ventures, with a target of £30 million (≈ $37.5 million) to be deployed over five years. The fund builds on a £3.5 million (≈ $4.4 million) pilot that backed AI‑driven diagnostics, upright radiotherapy and digital support...
Worried About Alzheimer's? This Type Of Exercise May Be Protective
A 24‑week resistance‑training program for adults aged 65‑80 reduced a brain‑volume signature linked to Alzheimer’s disease, especially among participants with early amyloid‑beta biomarkers. MRI scans showed adaptive thinning in vulnerable regions, and those changes correlated with better performance on executive‑function...
MRNA Vaccines Activate Unconventional CD8+ T Cells
A recent study published in *Nature Immunology* shows that mRNA COVID‑19 vaccines trigger a previously underappreciated subset of CD8+ T cells with innate‑like characteristics. These unconventional cells, resembling mucosal‑associated invariant T (MAIT) and γδ T cells, expand rapidly after the...
The Oncology Postcode Lottery
Patients in Blackpool, Knowsley and Kingston upon Hull face up to twice the risk of premature cancer death compared with England’s top‑performing regions, contributing to roughly 28,400 excess deaths each year. Decades of uneven policy have concentrated specialist services in...
Innovation for a New Era of Cancer Care
The UK’s National Cancer Plan, released earlier this year, prioritises expanding genomic testing, liquid biopsies, and a national inherited cancer registry to modernise cancer pathways. Johnson & Johnson argues that linking these precision diagnostics to innovative therapies is essential for...
What Will Be the Ultimate Test of the National Cancer Plan’s Success?
Britain’s new National Cancer Plan aims for three‑quarters of patients diagnosed from 2035 to be cancer‑free or thriving after five years, but experts warn that achieving this hinges on bolstering the research ecosystem, expanding the specialist workforce, and providing long‑term...
Bedside to Bench: Reducing Steps in Clinical Workflows
Healthcare providers are tackling inefficiencies by trimming unnecessary steps in clinical workflows. By deploying point‑of‑care technologies such as mobile computer carts, clinicians can document, review data, and place orders directly at the bedside, reducing walk‑time and cognitive load. Ergonomic designs...
New Federal Medicaid Rules Require One Month of Work. Some States Demand More.
Under the federal Medicaid work‑requirement law signed by President Trump, most states must verify that applicants have worked, studied, or volunteered for at least one month. Republican‑led states such as Indiana and Idaho have pushed the bar to three consecutive...
As US Birth Rate Falls, Feds’ Response May Make Pregnancy More Dangerous
U.S. births slipped to 3.6 million in 2025, a 1% drop from the previous year, pushing the fertility rate to 53.1 per 1,000 women – the lowest since 2007. The Trump administration is repurposing Title X, the nation’s sole federal family‑planning program,...
Decoding HBx–Smc6 Interaction: Advancing HBV Inhibition
A study in Cell Research reveals how hepatitis B virus protein HBx binds the host Smc6 subunit, triggering ubiquitin‑mediated degradation that lifts restriction on cccDNA and sustains infection. Cryo‑EM resolved the interface at near‑atomic resolution, identifying a pocket on Smc6 and...
DELO Expands Medical Electronics Portfolio with Five New IBOA-Free Adhesives
DELO Industrial Adhesives has introduced five new IBOA‑ and TPO‑free adhesives for medical electronics, adapting proven semiconductor and consumer‑electronics formulations for biocompatible use. The flagship MG4202 cures in just one second under a 1000 mW/cm² LED and operates from –40 °C to...
Should I Be Doing SIJ Cluster Tests in Suspected Axial Spondyloarthritis?
SIJ cluster testing is unlikely to change management decisions when axial spondyloarthritis is suspected. Pain localization in the lumbopelvic area is notoriously unreliable, and inflammatory musculoskeletal conditions often present with overlapping patterns of enthesitis, SIJ pain, back pain, and hip...
Doctor Care Anywhere Selects Tandem Health as AI Care Partner for Virtual Clinical Workflows
Doctor Care Anywhere, a leading UK digital health provider, has partnered with Tandem Health to embed its AI operating system into the virtual primary‑care platform. The integration will automatically capture consultations and generate structured medical records for the company’s 60,000...
Phantom Neuro Secures Approval for Muscle-Machine Interface Trial
Phantom Neuro has received regulatory clearance to launch its first‑in‑human trial of the Phantom X muscle‑machine interface in Melbourne, Australia. The early feasibility study, called CYBORG, will enroll up to ten unilateral below‑elbow amputees who will receive a single outpatient implant...
Boehringer Ingelheim and Zai Lab Team up for Dual DLL3 Therapy Study
Boehringer Ingelheim and Zai Lab have launched a Phase Ib/II trial that pairs Boehringer’s DLL3‑directed T‑cell engager obrixtamig with Zai Lab’s DLL3‑targeting ADC zoci. The study will evaluate safety, tolerability and early efficacy in patients with extensive‑stage small‑cell lung cancer and other neuroendocrine...
Boehringer Ingelheim and Zai Lab Team up for Dual DLL3 Therapy Study
German pharma giant Boehringer Ingelheim and China‑based Zai Lab announced a clinical collaboration to evaluate a dual DLL3‑targeting regimen in extensive‑stage small‑cell lung cancer and other neuroendocrine tumors. The Phase Ib/II study will combine Boehringer’s bispecific DLL3/CD3 T‑cell engager obrixtamig with...
Medicine Misses the Mark on African and Black Hair Health
Black and African patients remain dramatically underrepresented in dermatology, especially alopecia research, creating a knowledge gap that hampers accurate diagnosis and treatment. An undergraduate survey of ten participants revealed that hair loss is frequently linked to chemical straightening, tight braids,...
Freya Biosciences Advances Microbial Treatment for IVF Implantation Failure
Freya Biosciences announced that its microbial immunotherapy designed to address IVF implantation failure has progressed to a Phase 2 mid‑stage trial after demonstrating safety and early efficacy in healthy volunteers. The therapy leverages modulation of the uterine microbiome to improve endometrial...
AOP Health Reports the US FDA Approval Rapiblyk (Landiolol) for Pediatric Patients with Supraventricular Tachycardia
The U.S. Food and Drug Administration has granted approval for Rapiblyk (landiolol) for pediatric patients from birth through 17 years old suffering from supraventricular tachycardia (SVT). The decision follows the LANDI‑PED trial, which enrolled 60 children and demonstrated a greater...
Oral Frailty in Seniors: Risks, Outcomes, Solutions
A new scoping review in BMC Geriatrics maps oral frailty as a multidimensional geriatric syndrome, linking tooth loss, sarcopenia, cognitive decline, and polypharmacy to declining chewing, swallowing, and saliva production. The analysis shows how these functional losses trigger malnutrition, dysphagia,...
The Rise, Fall & Resurgence of the Freestanding ED
Freestanding emergency departments (FSEDs) surged from under 50 locations before 2005 to 566 by 2016, then collapsed as independent operators over‑leveraged and faced regulatory pushback. A second wave is underway, driven by health systems that view FSEDs as rapid‑deployment market...
The Association Between Acute Nutritional Changes and Prognosis in Ischemic Stroke Patients
Researchers analyzed 1,445 acute ischemic stroke patients and found that declines in the Prognostic Nutritional Index (PNI) during the first five days were independently linked to poorer functional outcomes at three months. Each 5‑unit increase in the change of PNI...
Commentary: The Distress of Psychological Adaptation in Nutritional Management Among People After Esophagectomy: An Interpretative Phenomenological Study
A recent interpretative phenomenological study of 16 esophagectomy survivors reveals that post‑surgical nutritional management is as much a psychological challenge as a physical one. The authors identified three core themes: cognitive‑behavioral adaptation to gastrointestinal symptoms, identity disruption within family food...
A Novel Nutritional Immune Risk Score Model for Long-Term Prognosis in Colorectal Cancer Using Clustering and Principal Component Analysis
Researchers created a Nutritional Immune Risk Score (NIRS) to improve long‑term prognosis for colorectal cancer patients by combining nutritional and tumor biomarkers. Using k‑means clustering and principal component analysis on 892 post‑resection cases, they identified four key variables—PNI, CEA, CA19‑9,...
Preoperative Nutritional Status and Its Association with Adverse Events Following Open Abdominal Aortic Aneurysm Repair
A retrospective study of 125 patients undergoing open abdominal aortic aneurysm repair found that pre‑operative malnutrition markers—low serum albumin, total protein, and Prognostic Nutritional Index (PNI)—were independently associated with aneurysm rupture at presentation and higher 30‑day mortality. Albumin, total protein...
Body Composition–Based Nutritional Status During Neoadjuvant Chemotherapy and Its Association with Relative Dose Intensity and Hematologic Toxicity in Patients with...
A 2026 Frontiers in Nutrition study of 92 gastric‑cancer patients examined body‑composition changes measured by bioelectrical impedance before and after neoadjuvant chemotherapy. The analysis found that losses in muscle mass, skeletal muscle mass, and total body water were linked to...
🔬 Drowning in Medical Papers? Meet Distill Medicine
Distill Medicine launches a personalized daily feed that curates the latest medical research for clinicians and researchers. The platform aggregates papers from PubMed, medRxiv, ClinicalTrials.gov and top journals, scoring each on relevance, journal prestige, recency and citations before delivering only...
Concierge Care for All: Yes, It Really Is That Simple
Matthew Holt proposes a universal concierge‑care system funded by a $2,000‑$3,000 annual voucher per American, directing patients to a primary‑care physician with a reduced panel of about 600 patients. The model would generate $1.2‑$1.8 million in revenue per physician, allowing salaries...
The 5 Top Health Lies & The Truth You Need to Feel Better Today
In this episode, Mel Robbins sits down with Dr. Mike Varshavsky, the most‑followed practicing physician online, to expose the five biggest health myths circulating on the internet and reveal the evidence‑based truths that can improve daily wellbeing. Dr. Mike explains...
Can a Patella Band Help Ease Your Knee Pain?
A patella band is an adjustable strap worn just below the kneecap that applies gentle pressure to the patellar tendon, redistributing force during high‑impact activities. Sports medicine physician Dr. Dominic King explains that correct placement—directly under the kneecap—can reduce pain...
A Colorado Hospital Profits From Resolving Language Barriers
Grand River Health, a 25‑bed hospital in Rifle, Colorado, launched a language‑access program that trains bilingual staff as certified medical interpreters. By shifting from costly virtual services to in‑house interpreters, the hospital reduced interpreter expenses by roughly two‑thirds and saw...
NY Home Care Workers Hunger Strike Over 24‑Hour Shifts
Home care workers in New York are set to begin a hunger strike on Thursday as they fight to ban 24-hour shifts. The city and state seem prepared to wait it out, as Hochul and Mamdani work behind the scenes...
Menopause Hormone Therapy May Influence Triple‑negative Breast Cancer Risk
Amen. I wrote about this in detail in my Substack about Triple Negative Breast Cancer and Menopause Hormone Therapy: https://open.substack.com/pub/drjordanemont/p/cancer-cases-triple-negative-breast?utm_campaign=post-expanded-share&utm_medium=post%20viewer
Join Us: When RCM Becomes a Strategic Asset—Lessons From Luminis Health Imaging
Two years after adopting a new revenue cycle management (RCM) platform, Luminis Health Imaging reports measurable financial gains. The second‑generation system delivered deeper analytics, enabling higher clean claim rates, fewer resubmissions, and faster cash collections. A data‑driven overhaul of prior‑authorization...
Stenting Advances Treatment for Post‑thrombotic Syndrome
Stenting for Post-Thrombotic Syndrome — A Step Forward {Editorial} [Apr 13, 2026] Flumignan & Nakano @NEJM https://t.co/w559CHaTON #NCT03250247 #VTE
Endovascular Therapy Shows Promise for Post‑Thrombotic Syndrome
Endovascular Therapy for Post-Thrombotic Syndrome — A Randomized Trial [Apr 13, 2026] Vedantham et al. for the C-TRACT [Chronic Venous Thrombosis: Relief with Adjunctive Catheter-Directed Therapy] Trial Investigators @NEJM https://t.co/Ayd4Fa0ARl #NCT03250247 #VTE https://t.co/6iD1NUQdgX
Accelerated Biological Aging Raises Dementia Risk in Women
Epigenetic Clocks of Biological Aging and Risk of Incident Mild Cognitive Impairment and Dementia: The Women's Health Initiative Memory Study "In this cohort study of older women, accelerated biological aging measured by AgeAccelGrim2 was associated with higher risk of incident MCI/probable...
Americans Trust Career Scientists Over Agency Leaders
Stark Divide: Americans More Confident in Career Scientists at U.S. Health Agencies Than Leaders A new survey by the Annenberg Public Policy Center finds that 67% of Americans have confidence in career scientists working at U.S. federal health agencies, compared with...